Proxiscan device for Prostate Cancer

Phase < 1

Waitlist Available

Led By Benjamin Franc, MD

Research Sponsored by Radiological Associates of Sacramento Medical Group Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within on month of scan and corresponding mri

Awards & highlights

No Placebo-Only Group

Summary

This is a small study to determine if probe, similar to an ultrasound probe, can detect prostate cancer more specifically than other imaging studies in patients with a positive prostate cancer biopsy.

Eligible Conditions

Prostate Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within on month of scan and corresponding mri

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within on month of scan and corresponding mri

This trial's timeline: 3 weeks for screening, Varies for treatment, and within on month of scan and corresponding mri for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Detection of PSMA antibody (ProstaScint)uptake patterns measured by Proxiscan in comparison with anatomic biopsy reports, conventional SPECT and MRI scans within one month of Proxiscan